Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Zou

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|September 1, 1996
[Clinical study on treating asthma of cold type with wenyang tongluo mixture]J P Zou, F Q Gu, W J Liao
Research in Immunology|September 1, 1995
A sequence of cellular and molecular events involved in IL12-induced tumour regressionH Fujiwara, J P Zou, S Herrmann, et al.
Oncogene|June 10, 1998
The BRCA2 is a histone acetyltransferaseH Siddique, J P Zou, V N Rao, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1991
Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unitJ Shimizu, J P Zou, K Ikegame, et al.
Journal of Cell Science|June 1, 1996
Interferon-independent activation of (2'-5') oligoadenylate synthetase in Friend erythroleukemia cell variants exposed to HMBAS Salzberg, A Heller, J P Zou, et al.
Optics Letters|December 9, 2004
Repetition rate increase and diffraction-limited focal spots for a nonthermal-equilibrium 100-TW Nd:glass laser chain by use of adaptive opticsB Wattellier, J Fuchs, J P Zou, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cellsJ P Zou, J Shimizu, K Ikegame, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hostsJ Shimizu, J P Zou, K Ikegame, et al.
Oncology Reports|February 19, 1999
Structure and expression of variant BRCA2a lacking the transactivation domainJ P Zou, Y Hirose, H Siddique, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burdenJ P Zou, T Nagata, N Yamamoto, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|September 1, 1996
[Clinical study on treating asthma of cold type with wenyang tongluo mixture]J P Zou, F Q Gu, W J Liao
Research in Immunology|September 1, 1995
A sequence of cellular and molecular events involved in IL12-induced tumour regressionH Fujiwara, J P Zou, S Herrmann, et al.
Oncogene|June 10, 1998
The BRCA2 is a histone acetyltransferaseH Siddique, J P Zou, V N Rao, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1991
Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unitJ Shimizu, J P Zou, K Ikegame, et al.
Journal of Cell Science|June 1, 1996
Interferon-independent activation of (2'-5') oligoadenylate synthetase in Friend erythroleukemia cell variants exposed to HMBAS Salzberg, A Heller, J P Zou, et al.
Optics Letters|December 9, 2004
Repetition rate increase and diffraction-limited focal spots for a nonthermal-equilibrium 100-TW Nd:glass laser chain by use of adaptive opticsB Wattellier, J Fuchs, J P Zou, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cellsJ P Zou, J Shimizu, K Ikegame, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hostsJ Shimizu, J P Zou, K Ikegame, et al.
Oncology Reports|February 19, 1999
Structure and expression of variant BRCA2a lacking the transactivation domainJ P Zou, Y Hirose, H Siddique, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burdenJ P Zou, T Nagata, N Yamamoto, et al.
Pageof 3